Cost-effectiveness analysis in the treatment of heavy menstrual bleeding in Spain
article
OA: closed
CC0
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This cost-effectiveness analysis compared different treatment options for heavy menstrual bleeding in Spain.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (19)
- A Cost-Utility Analysis of Abdominal Hysterectomy Versus Transcervical Endometrial Resection for the Surgical Treatment of Menorrhagia via openalex
- Cost-utility of levonorgestrel intrauterine system compared with hysterectomy and second generation endometrial ablative techniques in managing patients with menorrhagia in the UK via openalex
- Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest via openalex
- FIGO classification system (PALM‐COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age via openalex
- Levonorgestrel Intrauterine System versus Medical Therapy for Menorrhagia via openalex
- Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest via openalex
- doi:10.1111/j.1471-0528.1998.tb10172.x via openalex
- doi:10.1016/s1701-2163(16)34151-2 via openalex
- doi:10.3109/13625180903427675 via openalex
- doi:10.1016/j.contraception.2006.03.024 via openalex
- doi:10.1136/bmj.c3929 via openalex
- doi:10.1016/j.jval.2012.11.011 via openalex
- doi:10.1093/humrep/del478 via openalex
- doi:10.1093/humrep/del088 via openalex
- doi:10.1007/s10198-010-0244-4 via openalex
- doi:10.1016/s0213-9111(02)71933-x via openalex
- doi:10.2165/00019053-200017050-00006 via openalex
- doi:10.3109/13625187.2010.532999 via openalex
- doi:10.1016/j.ejogrb.2010.08.019 via openalex
Source provenance
- openalex
- last seen: 2026-05-11T06:27:45.971503+00:00
License: CC0
· commercial use OK